Table 2.
Tapering schedule of investigational medicinal products
Last maintenance dose | Days* 1–7 | Days* 8–14 | Days* 15–21 | Days* 22–28 |
V6 dose level | V5 dose | V4 dose | V3 dose | V2 dose |
V5 dose level | V4 dose | V3 dose | V2 dose | – |
V4 dose level | V3 dose | V2 dose | – | – |
V3 dose level | V2 dose | – | – | – |
V2 dose level | – | – | – | – |
*Days after the end of study visit (V10).